SCHEMBL6460409

SCHEMBL6460409

Cc1c([C@](C)(C(=O)O)C2CCC2)c2c(F)c(O)ccc2n1C(=O)c1ccc(Cl)c(F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.34
HSD11B1 P28845 3/20 0.32
AKR1C3 P42330 2/20 0.32
AKR1C2 P52895 2/20 0.32
F10 P00742 1/20 0.31
TACR2 P21452 4/20 0.31
TACR3 P29371 4/20 0.31
TACR1 P25103 3/20 0.31
MGLL Q99685 1/20 0.31
MAOB P27338 1/20 0.31
RORC P51449 1/20 0.31
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
GLA P06280 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
HSD17B10 Q99714 1/20 0.30
PTGS1 P23219 1/20 0.30
PTGS2 P35354 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6464703 0.98 PDE2A (0.34) PDE2AHSD11B1AKR1C3AKR1C2TACR2
SCHEMBL6428233 0.94 HSD11B1 (0.34) HSD11B1AKR1C3AKR1C2KDM4ELMNA
SCHEMBL6428229 0.92 ALDH1A1 (0.35) HSD11B1AKR1C3AKR1C2PTGS1PTGS2
SCHEMBL6424325 0.92 MEN1 (0.33) PDE2AHSD11B1AKR1C3AKR1C2
SCHEMBL6456664 0.90 PDE2A (0.35) PDE2AAKR1C3AKR1C2F10TACR2
SCHEMBL6426851 0.90 MEN1 (0.33) PDE2AHSD11B1AKR1C3AKR1C2
SCHEMBL6425722 0.89 AKR1C3 (0.39) AKR1C3AKR1C2MGLLKDM4ELMNA
SCHEMBL6453546 0.89 PDE2A (0.35) PDE2AAKR1C3AKR1C2F10TACR2
SCHEMBL6428282 0.87 AKR1C3 (0.39) AKR1C3AKR1C2MGLLKDM4ELMNA
SCHEMBL6426874 0.86 ALDH1A1 (0.37) HSD11B1AKR1C3AKR1C2MGLLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 PDE2A 846/4885HSD11B1 1120/4885AKR1C3 577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.